Clinical Trial Update: A Trial of HRS-4508 in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of HRS-4508 for locally advanced or metastatic non-small cell lung cancer. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• HRS-4508

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Solid Tumor | Phase 2 | Status: RECRUITING